Edilytics

@edilytics

Precision analytics for genome editing. Creators of CRISPResso2.

Edilytics
@edilytics
Apr 7, 2025
Thanks for using CRISPResso!
Profluent
@ProfluentBio
Apr 4, 2025
Scientific sharing fuels progress. Our friends at @Edilytics developed CRISPResso, an open-source CRISPR analysis tool built for researchers. Together with OpenCRISPR-1, the future of customizable gene editing is more accessible than ever. Check it out: edilytics.com/#crispresso
Edilytics
@edilytics
Feb 7, 2025
We are thrilled to be a part of @BioUtah!
BioUtah
@BioUtah
Feb 7, 2025
🎉 Welcome, @Edilytics, to @BioUtah! Their flagship product, CRISPResso, is the industry standard for analyzing genome editing events from NGS data, supporting diverse editing modalities with 1,650+ citations in academia & industry. 🔗 Learn more: edilytics.com
Edilytics
@edilytics
Aug 23, 2024
We are excited to attend @CSHL's CRISPR Frontiers conference next week. Let us know if you are going and we can talk all things genome editing analysis!
Edilytics
@edilytics
Nov 22, 2023
Congratulations to @CRISPRTX and @VertexPharma for UK approval of Casgevy to treat sickle-cell disease and β-thalassaemia. Hope to continue to see more therapies brought closer to the clinic!
UK first to approve CRISPR treatment for diseases: what you need to know
From nature.com
Edilytics
@edilytics
Oct 24, 2023
Excellent talk @grunewaju! #esgct (Thanks for using CRISPResso in your slides and work)